Reviews Pristiq


No reviews yet.

Pristiq Drug Description
PRISTIQ®
(desvenlafaxine) Extended-Release Tablets, oral

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of Major Depressive Disorder (MDD) and other psychiatric disorders.
Anyone considering the use of PRISTIQ® or any other antidepressant in
a child, adolescent, or young adult must balance this risk with the clinical
need. Short-term studies did not show an increase in the risk of suicidality
with antidepressants compared to placebo in adults beyond age 24; there was
a reduction in risk with antidepressants compared to placebo in adults aged
65 and older. Depression and certain other psychiatric disorders are themselves
associated with increases in the risk of suicide. Patients of all ages who
are started on antidepressant therapy should be monitored appropriately and
observed closely for clinical worsening, suicidality, or unusual changes in
behavior. Families and caregivers should be advised of the need for close
observation and communication with the prescriber. PRISTIQ is not approved
for use in pediatric patients [see WARNINGS AND PRECAUTIONS,
Use in Specific Populations, and PATIENT
INFORMATION].

DRUG DESCRIPTION



What are the possible side effects of desvenlafaxine (Pristiq)?

Get emergency medical help if you have any of these signs of an allergic reaction: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Contact your doctor promptly if you have any of the following side effects, especially if they are new symptoms or if they get worse: mood changes, anxiety, panic attacks, trouble sleeping, irritability, agitation, aggressiveness, severe restlessness, mania (mental and/or physical hyperactivity), thoughts of suicide or hurting yourself....
Read All Potential Side Effects for Pristiq »




PRISTIQ is an extended-release tablet for oral administration that contains
desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD.
Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the
antidepressant venlafaxine, a medication used to treat major depressive, generalized
anxiety, social anxiety and panic disorders.
Desvenlafaxine is designated RS-4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
and has the empirical formula of C16H25NO2
(free base) and C16H25NO2•C4H6O4•H2O
(succinate monohydrate). Desvenlafaxine succinate monohydrate has a molecular
weight of 399.48. The structural formula is shown below.








Desvenlafaxine succinate is a white to off-white powder that is soluble in
water. The solubility of desvenlafaxine succinate is pH dependent. Its octanol:aqueous
system (at pH 7.0) partition coefficient is 0.21.
PRISTIQ is formulated as an extended-release tablet for once-a-day oral administration.
Each tablet contains 76 or 152 mg of desvenlafaxine succinate equivalent to
50 or 100 mg of desvenlafaxine, respectively.
Inactive ingredients for the 50 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C
yellow #6.
Last reviewed on RxList: 7/29/2010




Pristiq Drug Description
PRISTIQ®
(desvenlafaxine) Extended-Release Tablets, oral

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of Major Depressive Disorder (MDD) and other psychiatric disorders.
Anyone considering the use of PRISTIQ® or any other antidepressant in
a child, adolescent, or young adult must balance this risk with the clinical
need. Short-term studies did not show an increase in the risk of suicidality
with antidepressants compared to placebo in adults beyond age 24; there was
a reduction in risk with antidepressants compared to placebo in adults aged
65 and older. Depression and certain other psychiatric disorders are themselves
associated with increases in the risk of suicide. Patients of all ages who
are started on antidepressant therapy should be monitored appropriately and
observed closely for clinical worsening, suicidality, or unusual changes in
behavior. Families and caregivers should be advised of the need for close
observation and communication with the prescriber. PRISTIQ is not approved
for use in pediatric patients [see WARNINGS AND PRECAUTIONS,
Use in Specific Populations, and PATIENT
INFORMATION].

DRUG DESCRIPTION



What are the possible side effects of desvenlafaxine (Pristiq)?

Get emergency medical help if you have any of these signs of an allergic reaction: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Contact your doctor promptly if you have any of the following side effects, especially if they are new symptoms or if they get worse: mood changes, anxiety, panic attacks, trouble sleeping, irritability, agitation, aggressiveness, severe restlessness, mania (mental and/or physical hyperactivity), thoughts of suicide or hurting yourself....
Read All Potential Side Effects for Pristiq »




PRISTIQ is an extended-release tablet for oral administration that contains
desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD.
Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the
antidepressant venlafaxine, a medication used to treat major depressive, generalized
anxiety, social anxiety and panic disorders.
Desvenlafaxine is designated RS-4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
and has the empirical formula of C16H25NO2
(free base) and C16H25NO2•C4H6O4•H2O
(succinate monohydrate). Desvenlafaxine succinate monohydrate has a molecular
weight of 399.48. The structural formula is shown below.








Desvenlafaxine succinate is a white to off-white powder that is soluble in
water. The solubility of desvenlafaxine succinate is pH dependent. Its octanol:aqueous
system (at pH 7.0) partition coefficient is 0.21.
PRISTIQ is formulated as an extended-release tablet for once-a-day oral administration.
Each tablet contains 76 or 152 mg of desvenlafaxine succinate equivalent to
50 or 100 mg of desvenlafaxine, respectively.
Inactive ingredients for the 50 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C
yellow #6.
Last reviewed on RxList: 7/29/2010




Pristiq Drug Description
PRISTIQ®
(desvenlafaxine) Extended-Release Tablets, oral

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of Major Depressive Disorder (MDD) and other psychiatric disorders.
Anyone considering the use of PRISTIQ® or any other antidepressant in
a child, adolescent, or young adult must balance this risk with the clinical
need. Short-term studies did not show an increase in the risk of suicidality
with antidepressants compared to placebo in adults beyond age 24; there was
a reduction in risk with antidepressants compared to placebo in adults aged
65 and older. Depression and certain other psychiatric disorders are themselves
associated with increases in the risk of suicide. Patients of all ages who
are started on antidepressant therapy should be monitored appropriately and
observed closely for clinical worsening, suicidality, or unusual changes in
behavior. Families and caregivers should be advised of the need for close
observation and communication with the prescriber. PRISTIQ is not approved
for use in pediatric patients [see WARNINGS AND PRECAUTIONS,
Use in Specific Populations, and PATIENT
INFORMATION].

DRUG DESCRIPTION



What are the possible side effects of desvenlafaxine (Pristiq)?

Get emergency medical help if you have any of these signs of an allergic reaction: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Contact your doctor promptly if you have any of the following side effects, especially if they are new symptoms or if they get worse: mood changes, anxiety, panic attacks, trouble sleeping, irritability, agitation, aggressiveness, severe restlessness, mania (mental and/or physical hyperactivity), thoughts of suicide or hurting yourself....
Read All Potential Side Effects for Pristiq »




PRISTIQ is an extended-release tablet for oral administration that contains
desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD.
Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the
antidepressant venlafaxine, a medication used to treat major depressive, generalized
anxiety, social anxiety and panic disorders.
Desvenlafaxine is designated RS-4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
and has the empirical formula of C16H25NO2
(free base) and C16H25NO2•C4H6O4•H2O
(succinate monohydrate). Desvenlafaxine succinate monohydrate has a molecular
weight of 399.48. The structural formula is shown below.








Desvenlafaxine succinate is a white to off-white powder that is soluble in
water. The solubility of desvenlafaxine succinate is pH dependent. Its octanol:aqueous
system (at pH 7.0) partition coefficient is 0.21.
PRISTIQ is formulated as an extended-release tablet for once-a-day oral administration.
Each tablet contains 76 or 152 mg of desvenlafaxine succinate equivalent to
50 or 100 mg of desvenlafaxine, respectively.
Inactive ingredients for the 50 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C
yellow #6.
Last reviewed on RxList: 7/29/2010




Pristiq Drug Description
PRISTIQ®
(desvenlafaxine) Extended-Release Tablets, oral

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of Major Depressive Disorder (MDD) and other psychiatric disorders.
Anyone considering the use of PRISTIQ® or any other antidepressant in
a child, adolescent, or young adult must balance this risk with the clinical
need. Short-term studies did not show an increase in the risk of suicidality
with antidepressants compared to placebo in adults beyond age 24; there was
a reduction in risk with antidepressants compared to placebo in adults aged
65 and older. Depression and certain other psychiatric disorders are themselves
associated with increases in the risk of suicide. Patients of all ages who
are started on antidepressant therapy should be monitored appropriately and
observed closely for clinical worsening, suicidality, or unusual changes in
behavior. Families and caregivers should be advised of the need for close
observation and communication with the prescriber. PRISTIQ is not approved
for use in pediatric patients [see WARNINGS AND PRECAUTIONS,
Use in Specific Populations, and PATIENT
INFORMATION].

DRUG DESCRIPTION



What are the possible side effects of desvenlafaxine (Pristiq)?

Get emergency medical help if you have any of these signs of an allergic reaction: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Contact your doctor promptly if you have any of the following side effects, especially if they are new symptoms or if they get worse: mood changes, anxiety, panic attacks, trouble sleeping, irritability, agitation, aggressiveness, severe restlessness, mania (mental and/or physical hyperactivity), thoughts of suicide or hurting yourself....
Read All Potential Side Effects for Pristiq »




PRISTIQ is an extended-release tablet for oral administration that contains
desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD.
Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the
antidepressant venlafaxine, a medication used to treat major depressive, generalized
anxiety, social anxiety and panic disorders.
Desvenlafaxine is designated RS-4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
and has the empirical formula of C16H25NO2
(free base) and C16H25NO2•C4H6O4•H2O
(succinate monohydrate). Desvenlafaxine succinate monohydrate has a molecular
weight of 399.48. The structural formula is shown below.








Desvenlafaxine succinate is a white to off-white powder that is soluble in
water. The solubility of desvenlafaxine succinate is pH dependent. Its octanol:aqueous
system (at pH 7.0) partition coefficient is 0.21.
PRISTIQ is formulated as an extended-release tablet for once-a-day oral administration.
Each tablet contains 76 or 152 mg of desvenlafaxine succinate equivalent to
50 or 100 mg of desvenlafaxine, respectively.
Inactive ingredients for the 50 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C
yellow #6.
Last reviewed on RxList: 7/29/2010




Pristiq Drug Description
PRISTIQ®
(desvenlafaxine) Extended-Release Tablets, oral

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of Major Depressive Disorder (MDD) and other psychiatric disorders.
Anyone considering the use of PRISTIQ® or any other antidepressant in
a child, adolescent, or young adult must balance this risk with the clinical
need. Short-term studies did not show an increase in the risk of suicidality
with antidepressants compared to placebo in adults beyond age 24; there was
a reduction in risk with antidepressants compared to placebo in adults aged
65 and older. Depression and certain other psychiatric disorders are themselves
associated with increases in the risk of suicide. Patients of all ages who
are started on antidepressant therapy should be monitored appropriately and
observed closely for clinical worsening, suicidality, or unusual changes in
behavior. Families and caregivers should be advised of the need for close
observation and communication with the prescriber. PRISTIQ is not approved
for use in pediatric patients [see WARNINGS AND PRECAUTIONS,
Use in Specific Populations, and PATIENT
INFORMATION].

DRUG DESCRIPTION



What are the possible side effects of desvenlafaxine (Pristiq)?

Get emergency medical help if you have any of these signs of an allergic reaction: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Contact your doctor promptly if you have any of the following side effects, especially if they are new symptoms or if they get worse: mood changes, anxiety, panic attacks, trouble sleeping, irritability, agitation, aggressiveness, severe restlessness, mania (mental and/or physical hyperactivity), thoughts of suicide or hurting yourself....
Read All Potential Side Effects for Pristiq »




PRISTIQ is an extended-release tablet for oral administration that contains
desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD.
Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the
antidepressant venlafaxine, a medication used to treat major depressive, generalized
anxiety, social anxiety and panic disorders.
Desvenlafaxine is designated RS-4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
and has the empirical formula of C16H25NO2
(free base) and C16H25NO2•C4H6O4•H2O
(succinate monohydrate). Desvenlafaxine succinate monohydrate has a molecular
weight of 399.48. The structural formula is shown below.








Desvenlafaxine succinate is a white to off-white powder that is soluble in
water. The solubility of desvenlafaxine succinate is pH dependent. Its octanol:aqueous
system (at pH 7.0) partition coefficient is 0.21.
PRISTIQ is formulated as an extended-release tablet for once-a-day oral administration.
Each tablet contains 76 or 152 mg of desvenlafaxine succinate equivalent to
50 or 100 mg of desvenlafaxine, respectively.
Inactive ingredients for the 50 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline
cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl
alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C
yellow #6.
Last reviewed on RxList: 7/29/2010





Other reviews about Pristiq on wordpress

Wyeth Receives Approvable Precisely out of FDA so as to PRISTIQ as proxy for the
  by zlishlomo
Wyeth Receives Approvable Pneumatogram out FDA in place of PRISTIQ in preference to the Screed speaking of Vasomotor Symptoms In league amongst Menopause(The San Francisco Secret agent) COLLEGEVILLE, […]


Wyeth Receives Approvable Precisely out of FDA so as to PRISTIQ as proxy for the
  by zlishlomo
Wyeth Receives Approvable Pneumatogram out FDA in place of PRISTIQ in preference to the Screed speaking of Vasomotor Symptoms In league amongst Menopause(The San Francisco Secret agent) COLLEGEVILLE, […]


Quick rebranding update: Soma, Lyrica/Gabapentin, Pristiq/Effexor
  by ludditeandroid
Soma (Carisoprodol)  has been available in a generic 350 mg strength for years now.  I'm not sure when this started, but I just saw a trade magazine ad […]


Generic Drug Update: Effexor XR generic way ahead of schedule, maybe not available for long
  by ludditeandroid
I wrote this awhile back: I’ve wrote about Pristiq before.  It’s very similar to Effexor (which is already generic) and Effexor XR (which will go generic within a few […]


Pristiq (desvenlafaxine) information
  by Kass
Here's a list of compiled links providing information on Pristiq. These links include info from my blog and others. Pristiq posing as pristine Chemical Imbalance Watch Pristiq gains ground with FDA Pristiq's […]


Pristiq Information
  by Kass
Here's a list of compiled links providing information on Pristiq. These links include info from my blog and others. Pristiq posing as pristine Chemical Imbalance Watch Pristiq gains ground with FDA Pristiq's […]


Switching from Effexor to Pristiq
  by karljetta
Well, I have some interesting news to share today. Today is the second day in my switch from effexor to pristiq. Now there are several reasons why I […]


Dealing with Anxiety and Death
  by karljetta
First a quick update about my switching from effexor to pristiq. I am now on the fifth day being completely free from effexor. I switched from 225mg of […]


efexor xr, pristiq, cipramil and lexapro
  by zephyr
Today my pdoc started me on Pristiq. He explained how Efexor is changed into Pristiq (desvenlafaxine) by the liver, so it is essentially the same med by the time it goes […]


Pristiq medication
  by zephyr
Well, it looks like Pristiq is going to work for because at least I have stopped crying. That's a good start. I am getting the usual side-effects of dry […]



Other reviews about Pristiq on web:

PRISTIQ (desvenlafaxine), a prescription medication approved for the treatment of depression. PRISTIQ is a prescription medication approved for the treatment of ...


Desvenlafaxine (Pristiq), also known as O-desmethylvenlafaxine, is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class developed and marketed by Wyeth ... Desvenlafaxine - Wikipedia, the free encyclopedia


Accurate, FDA approved Pristiq information for healthcare professionals and patients - brought to you by Drugs.com. Pristiq Official FDA information, side effects and uses.


Pristiq (desvenlafaxine) is used to treat major depressive disorder in adults. Includes Pristiq side effects, interactions and indications. Pristiq Information from Drugs.com


Learn about the prescription medication Pristiq (Desvenlafaxine Extended-Release Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient ... Pristiq (Desvenlafaxine Extended-Release Tablets) Drug Information ...


Tracking your progress may help you and your health care professional assess how you respond to PRISTIQ (desvenlafaxine). What to Expect from PRISTIQ Antidepressant - PRISTIQ.com


Learn more about Pristiq. Find the Web's best health guides, medical reports, news, videos and tools for Pristiq. Share Pristiq experiences and get advice from experts. Pristiq Overview - References, Advice, News, Videos, Coping & Support


Find patient medical information for Pristiq Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Pristiq Oral : Uses, Side Effects, Interactions, Pictures ...


Pristiq Information, Learn About Pristiq, Pristiq Forums, How to Take Pristiq, Pristiq Side Effects, Pristiq Interactions, Discussion Threads, Medication Warnings, Pristiq ... Pristiq - The People's Medicine Community


Jan Drugs is the best online Canadian pharmacy offering safe and affordable discount Pristiq with great service from Canada. Buy Pristiq | Jan Drugs Online Canadian Pharmacy





Featured Reviews

Reviews Elavil

Elavil Drug Description Elavil (amitriptyline HCI) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in...
Read More  |  Review This
Reviews Topamax

Topamax Drug Description TOPAMAX® (topiramate) Tablets TOPAMAX® (topiramate) Capsules DRUG DESCRIPTION What are the possible side effects of topiramate (Topamax, Topamax Sprinkle)? Get emergency medical help if you...
Read More  |  Review This
Reviews Travoprost Ophthalmic Solution

Travatan Z Drug Description Travatan Z® (travoprost ophthalmic) Solution 0.004% Sterile DRUG DESCRIPTION What are the possible side effects of travoprost ophthalmic (Travatan)? Get emergency medical help if you have any of...
Read More  |  Review This
Reviews Antivenin

Rattlesnake Antivenin Drug Description Rattlesnake Antivenin [Crotalidae Polyvalent) (Equine)] IMPORTANT Pit viper bites may cause severe tissue damage or fatal envenomation, or both. The physician responsible for treatment of an envenomated...
Read More  |  Review This
Reviews Fluorescein Injection

Ak-Fluor Drug Description AK-FLUOR® (fluorescein) Injection, USP 10% & 25% Sterile Solution DRUG DESCRIPTION AK-FLUOR® (Fluorescein Injection, USP) is a sterile solution in Water for Injection, of Fluorescein prepared with...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....